Australia: Lives Could Be Saved with New Hepatitis C Therapy

In a letter to the Medical Journal of Australia, a Monash University-led team is asking for hepatitis C virus patients to gain improved access to drugs to prevent liver related deaths.

Hepatitis C virus (HCV) infection is a major public health burden in Australia, with estimates of 230,000 people chronically infected.

The research team are calling for the government to subsidize a new therapy which has high cure rates, known as direct acting antiviral (DAA) therapy.

Read more ...

Labels: , ,